Dan Manea - 01 Jun 2023 Form 4 Insider Report for INSULET CORP (PODD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Jun 2023, 16:09:40 UTC
Prior SEC filing
01 Mar 2023
Next SEC filing
21 Jun 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Patricia K. Dolan, attorney-in-fact

Key filing fact

Dan Manea filed Form 4 for INSULET CORP (PODD) on 02 Jun 2023.

Key facts

  • This page summarizes Dan Manea's Form 4 filing for INSULET CORP (PODD).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Jun 2023, 16:09.

Change

  • Previous filing in this sequence was filed on 01 Mar 2023.
  • Current net transaction value: -$90,463.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PODD transaction

Common Stock

Tax liability

Transaction value
$90,463
Shares
-332
Change %
-6.6%
Price
$272.48
Shares after
4,697
Date
01 Jun 2023
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations.

Footnote F2

Includes 81 shares acquired under the Insulet Corporation Employee Stock Purchase Plan on May 31, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .